SCHEMBL19981555

SCHEMBL19981555

Cn1nc(Nc2cc(-c3ccc(F)c(NC(=O)c4cc5c(s4)CC(C)(C)[C@@H]5O)c3)nn(C)c2=O)cc1CCN1CCC1

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9984471 0.94 BTK (0.40) BTK
SCHEMBL2490951 0.94 BTK (0.40) BTK
SCHEMBL9985016 0.94 BTK (0.40) BTK
SCHEMBL2489760 0.88 BTK (0.40) BTK
SCHEMBL9984473 0.88 BTK (0.40) BTK
SCHEMBL9985937 0.88 BTK (0.40) BTK
SCHEMBL12026174 0.86 BTK (0.39) BTK
SCHEMBL2490213 0.86 BTK (0.39) BTK
SCHEMBL9984571 0.86 BTK (0.39) BTK
SCHEMBL9984635 0.82 BTK (0.41) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365970-B1 PYRIDAZINONES AND THEIR USE AS BTK INHIBITORS GILEAD CONNECTICUT INC (US) 2018-03-21 EP disclosed